Mitochondrial Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-06-22
Clinical Trial Update: A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion [Phase 1]
First-in-human Phase 1 trial evaluating the safety of infusing autologous CD34+ cells enriched with placenta-derived allogeneic mitochondria…